Mohammed M. Massoud
Al Mansurah, DK 35516, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pyranotacrines as prospective multi-target compounds against Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry
Published: October 14, 2025
New Benzimidazole Scaffolds Tagged With Isatin/Thiourea Motifs as Anti-Cancer Agents: Promising Approach for VEGFR-2 Inhibition.
Journal: Archiv der Pharmazie
Published: April 12, 2025
Benzimidazole-based protein kinase inhibitors: Current perspectives in targeted cancer therapy.
Journal: Chemical biology & drug design
Published: May 05, 2022
In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors.
Journal: Chemical biology & drug design
Published: March 25, 2021
Effect of a newly synthesized quinoline-based compound (PPQ-8) on murine schistosomiasis mansoni.
Journal: Journal of helminthology
Published: February 08, 2020
In vivo studies of the effect of PPQ-6, a quinoline-based agent against Schistosoma mansoni in mice.
In vivo studies of the effect of PPQ-6, a quinoline-based agent against Schistosoma mansoni in mice.
Journal: Experimental parasitology
Published: November 08, 2019
Biological evaluation of newly synthesized quinoline-based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study.
Journal: Experimental parasitology
Published: April 18, 2019
Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
Journal: Archiv der Pharmazie
Published: December 05, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026